Macrophagic Activation and Immunophenotypic Profile of Patients With Gaucher's Disease

Evaluation of Macrophagic Activation and Immunophenotypic Profile of Patients With Gaucher's Disease.

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01206673

Acronym

Gaucher

Enrollment

Registered

2010-09-22

Start date

2009-12-01

Completion date

2011-07-01

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Gaucher's Disease

Brief summary

The aim of this study is to evaluate macrophaging activity and immunologic profile of patients with Gaucher 's disease. For this, one blood sampling will be performed.

Interventions

OTHERBlood sampling

One blood sampling is required for the research

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

BASIC_SCIENCE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adults (age equal or above 18. * Patients with Gaucher 's disease treated in the "Grand Ouest" competence center * patients affiliated to social security * Informed consent signed

Exclusion criteria

\- Children (age\<18)

Design outcomes

Primary

Measure	Time frame
To determine the implication of acquired and inherent immunity in the Gaucher's clinical phenotype at moment of blood sampling	—

Secondary

Measure	Time frame
to find new activity mark for Gaucher's disease by studying macrophagic activation's markers.	—

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 15, 2026